9,728
Total Claims
$1.4M
Drug Cost
993
Beneficiaries
$1,378
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
+31%
Cost per patient vs peers
$1,378 vs $1,054 avg
+19%
Brand preference vs peers
15.6% vs 13.1% avg
Brand vs Generic
84% generic
Brand: 1,520 claims · $1.2M
Generic: 8,208 claims · $187K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 516 | $466K |
| Sacubitril/Valsartan | 292 | $329K |
| Rivaroxaban | 215 | $199K |
| Dronedarone Hcl | 53 | $58K |
| Alirocumab | 37 | $44K |
| Empagliflozin | 33 | $29K |
| Ranolazine | 129 | $22K |
| Evolocumab | 18 | $17K |
| Metoprolol Succinate | 759 | $14K |
| Atorvastatin Calcium | 744 | $11K |
| Icosapent Ethyl | 20 | $10K |
| Diltiazem Hcl | 290 | $8,992 |
| Rosuvastatin Calcium | 491 | $8,567 |
| Propafenone Hcl | 25 | $7,606 |
| Ezetimibe | 171 | $7,411 |
Prescribing Profile
60
Unique Drugs
$1.0M
Patient Profile
76
Avg Age
44%
Female
1.42
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About